Paeds Cases · paediatric-dermatology
Reassure and counsel a parent about cradle cap — OSCE
OSCE communication and counselling station: explaining to the anxious parent of a six-week-old boy what cradle cap is, why it is not an infection and not a hygiene problem, why no swab or test is needed, how to manage it with the gentle scalp care, and when to return — addressing the parental distress, the borrowed potent steroid, and the expected clearance by six to twelve months, in plain language.
On this page
Study tools
Target exams
Communication framework
Establish what the parents already understand and feel. Ask them to tell you, in their own words, what they have noticed and what they are most worried about. The anxiety about the infection, the guilt about the hygiene, the worry about the appearance and the permanence, and the decision to borrow the potent steroid are the four things you will spend the most time addressing, and you address them with the plain language and the reassurance of the benign course. Do not dismiss the anxiety — name it, and relieve it with the facts. [11]
Explain the diagnosis in the plain language, without the jargon. Tell them that their son has the cradle cap, which is a very common and completely benign condition of the young infant, in which a greasy yellow scale settles on the scalp, the eyebrows, and the skin folds. Explain that it is caused by the natural oils of the baby skin and a harmless yeast that lives on everyone's skin, and that it is neither an infection nor a sign of the poor hygiene, nor anything they did wrong. Translate the terms — the "seborrhoeic" simply means the oily-skin areas — and tell them plainly that nothing is wrong with their baby, who is feeding well, growing, and smiling. [5]
Address the borrowed potent steroid and the harm directly. Tell them to stop the potent steroid cream at once, because the strong steroid can thin and damage the delicate baby skin and can be absorbed, and the cradle cap does not need it. Reassure them that no harm has been done by the short use, but that the gentle measures are both safer and more appropriate. This is the safety-critical point of the consultation, and it is delivered without judgment. [5]
References3ShowHide
- [1]Victoire A, Magin P, Coughlan J, van Driel ML. Interventions for infantile seborrhoeic dermatitis (including cradle cap). Cochrane Database of Systematic Reviews, 2019.PMID 30828791
- [5]Patrizi A, Neri I, Ricci G, et al. Advances in pharmacotherapeutic management of common skin diseases in neonates and infants. Expert Opinion on Pharmacotherapy, 2017.PMID 28429969
- [11]Chernyshov PV, Vozianova SV, Chubar OV. Quality of Life of Infants, Toddlers and Preschoolers with Seborrhoeic, Allergic Contact and Atopic Dermatitis Before and During COVID-19 Pandemic. Dermatology and Therapy, 2021.PMID 34562266